Companies / Puma Biotechnology, Inc.

Puma Biotechnology, Inc.

Nasdaq: PBYICIK 1401667LOS ANGELES, CApumabiotechnology.com
Insider flow · last 90 daysNet sells $158.8K

Financials · FY2025

Revenue$228.37M
Net income$31.11M
Total debt$0
Cash$36.54M
Diluted EPS$0.61
Shares outstanding51.6M

Ownership

51.6M shares outstanding · as of Aug 3, 2026
15.3%Insiders
Ownership
Insiders15.29%7,890,375
Institutions72.68%37,516,108
Public float12.04%6,213,583

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Auerbach Alan HCEOPresident and CEO · Director · 10% owner
14.15%7,305,729
Nougues Maximo FChief Financial Officer
0.46%240,023
Hunt Douglas MSee Remarks
0.40%205,301
0.16%81,000
Moyes Jay MDirector
0.11%58,322

Institutional holders 156

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 12, 2026Moyes Jay M
Director
SellCommon Stock$158.8K-22K
-27.39%
58,322
0.11% of shares
medium
Jan 7, 2026Auerbach Alan H
CEO
SellCommon Stock$105.9K-18K
-0.25%
7,145,951
13.84% of shares
medium
Jan 6, 2026Auerbach Alan H
CEO
SellCommon Stock$99.0K-17K
-0.24%
7,163,963
13.88% of shares
low
Jan 7, 2026Nougues Maximo F
Executive
SellCommon Stock$37.7K-6K
-3.21%
193,284
0.37% of shares
low
Jan 7, 2026Hunt Douglas M
Executive
SellCommon Stock$29.5K-5K
-3.12%
155,907
0.30% of shares
low
Jan 6, 2026Nougues Maximo F
Executive
SellCommon Stock$26.5K-5K
-2.22%
199,689
0.39% of shares
low
Jan 6, 2026Hunt Douglas M
Executive
SellCommon Stock$23.2K-4K
-2.41%
160,921
0.31% of shares
low
Jun 11, 2026Miller Michael Patrick
Director
GrantCommon Stock$0+27K
+50.00%
81,000
0.16% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PBYI74587V107